Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianqing Stem Cell is a Chinese biotechnology company specializing in the research, development, and clinical application of stem cell technologies. The company focuses on the storage and therapeutic use of various stem cell types, including umbilical cord mesenchymal stem cells and hematopoietic stem cells. Tianqing Stem Cell operates a large-scale stem cell bank and research facility, providing services for both private storage and clinical research. Their therapeutic pipeline targets a range of conditions such as liver disease, autoimmune disorders, and degenerative conditions. The company is a key player in the regional biotech ecosystem in Jiangsu province, collaborating with hospitals for clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tian Qing Stem Cell.